Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

EDX Medical Group PLC (LSE:EDX) in AIM Spotlight: What Could Drive the Next Share-Price Move?

• The next assessment points include regulatory pathways andCapitalneeds, with execution andLiquiditycentral to valuation.

Ankur Sharma | 03 November 2026

Futura Medical plc (LSE:FUM) in AIM Spotlight: What Could Drive the Next Share-Price Move?

• The next assessment points includeRoyaltyreceipts and partner sales, with execution andLiquiditycentral to valuation.

Ankur Sharma | 03 November 2026

PureTech Health PLC (LSE:PRTC): London-listed Investor Focus Turns to Clinical Milestones as UK Markets Reassess Outlook

The principal near-term considerations include clinical milestones, funding runway and portfolio realisations.

Ankur Sharma | 03 November 2026

Smith & Nephew plc (LSE:SN.): Why FTSE 100 Investors Are Watching Its Next Move

On 3 November 2026, Smith & Nephew plc is part of the wider LondonEquitywatchlist as investors reassess product demand, innovation and commercial execution. A specific new company announcement or a confirmed single-session price catalyst has not been established for this article; attention is therefore …

Ankur Sharma | 03 November 2026

GSK plc (LSE:GSK): Why FTSE 100 Investors Are Watching Its Next Move

On 3 November 2026, GSK plc is part of the wider LondonEquitywatchlist as investors reassess product demand, innovation and commercial execution. A specific new company announcement or a confirmed single-session price catalyst has not been established for this article; attention is therefore best understood …

Ankur Sharma | 03 November 2026

Haleon PLC (LSE:HLN): Why FTSE 100 Investors Are Watching Its Next Move

On 3 November 2026, Haleon PLC is part of the wider LondonEquitywatchlist as investors reassess product demand, innovation and commercial execution. A specific new company announcement or a confirmed single-session price catalyst has not been established for this article; attention is therefore best understood …

Ankur Sharma | 03 November 2026

CVS Group plc (LSE:CVSG): FTSE 250 Investor Focus Turns to Clinical Recruitment as UK Markets Reassess Outlook

The principal near-term considerations include clinical recruitment, margins andAcquisitionintegration.

Ankur Sharma | 03 November 2026

New CFO for Convatec (LSE:CTEC): Fortrea finance chief Jill McConnell to take the reins

• McConnell becomes CFO and joins the Board on 1 March 2027, succeeding outgoing finance chief Fiona Ryder.

Divya Sood | 03 November 2026

Allergy Therapeutics (LSE:AGY) plans to leave AIM: thin free float and high costs drive the exit as Hong Kong stays in view

• The board cites a limited free float, poorLiquidityand the ongoing cost of maintaining the listing.

Divya Sood | 03 November 2026

Oxford Biomedica Shares Slip: Is the Cell and Gene Therapy CDMO Building a Durable Contract Manufacturing Base?

The company operates in the Healthcare sector and is listed on the London Stock Exchange.

Divya Sood | 03 November 2026
Support

Hi! How can we help you today?

Loading…